BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9660334)

  • 1. Multi-center clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects. 6-month results.
    Yukna RA; Callan DP; Krauser JT; Evans GH; Aichelmann-Reidy ME; Moore K; Cruz R; Scott JB
    J Periodontol; 1998 Jun; 69(6):655-63. PubMed ID: 9660334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and open flap debridement (DEBR) in human periodontal osseous defects: a 6 month pilot study.
    Radhakrishnan S; Anusuya CN
    J Int Acad Periodontol; 2004 Jul; 6(3):101-7. PubMed ID: 15368877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center clinical comparison of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) and ABM in human periodontal osseous defects. 6-month results.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2000 Nov; 71(11):1671-9. PubMed ID: 11128913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects. I. Clinical findings.
    Yukna RA; Krauser JT; Callan DP; Evans GH; Cruz R; Martin M
    J Periodontol; 2002 Jan; 73(1):123-8. PubMed ID: 11846193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of coralline calcium carbonate as a bone replacement graft material in human periodontal osseous defects.
    Yukna RA
    J Periodontol; 1994 Feb; 65(2):177-85. PubMed ID: 8158515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative evaluation of the effectiveness of an anorganic bone matrix/cell binding peptide with an open flap debridement in human infrabony defects: a clinical and radiographic study.
    Bhongade ML; Tiwari IR
    J Contemp Dent Pract; 2007 Sep; 8(6):25-34. PubMed ID: 17846668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal regeneration following use of ABM/P-1 5: a case report.
    Yukna R; Salinas TJ; Carr RF
    Int J Periodontics Restorative Dent; 2002 Apr; 22(2):146-55. PubMed ID: 12019710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of bioactive glass in the treatment of periodontal osseous defects in humans.
    Lovelace TB; Mellonig JT; Meffert RM; Jones AA; Nummikoski PV; Cochran DL
    J Periodontol; 1998 Sep; 69(9):1027-35. PubMed ID: 9776031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in the treatment isolated Class I gingival recession of defects: a pilot study.
    Nazareth CA; Cury PR
    J Periodontol; 2011 May; 82(5):700-7. PubMed ID: 21080787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the combination of anorganic bovine-derived hydroxyapatite matrix/cell-binding peptide (P-15) in particulate and hydrogel form as a bone replacement graft material in human periodontal osseous defects: 6-month reentry controlled clinical study.
    Matos SM; Guerra FA; Krauser J; Marques F; Ermida JM; Sanz M
    J Periodontol; 2007 Oct; 78(10):1855-63. PubMed ID: 18062107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone regeneration of localized chronic alveolar defects utilizing cell binding peptide associated with anorganic bovine-derived bone mineral: a clinical and histological study.
    Barboza EP; de Souza RO; Caúla AL; Neto LG; Caúla Fde O; Duarte ME
    J Periodontol; 2002 Oct; 73(10):1153-9. PubMed ID: 12416773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of calcium sulfate in combination with demineralized freeze-dried bone allograft for the treatment of human intraosseous defects.
    Aichelmann-Reidy ME; Heath CD; Reynolds MA
    J Periodontol; 2004 Mar; 75(3):340-7. PubMed ID: 15088870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyapatite cement implant for regeneration of periodontal osseous defects in humans.
    Brown GD; Mealey BL; Nummikoski PV; Bifano SL; Waldrop TC
    J Periodontol; 1998 Feb; 69(2):146-57. PubMed ID: 9526913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
    Batista EL; Novaes AB; Simonpietri JJ; Batista FC
    J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
    J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HTR polymer grafts in human periodontal osseous defects. I. 6-month clinical results.
    Yukna RA
    J Periodontol; 1990 Oct; 61(10):633-42. PubMed ID: 2231230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.